The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 356:729-731 February 15, 2007 Number 7
NextNext

Inactivated and Live Attenuated Influenza Vaccines in Young Children — How Do They Compare?
Nancy J. Cox, Ph.D., and Carolyn Buxton Bridges, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Belshe, R. B.
-PubMed Citation
Two quite different influenza vaccines are now licensed for use in the United States — a trivalent inactivated influenza vaccine that is administered intramuscularly and a live attenuated influenza vaccine that is administered by means of a nasal spray. The trivalent inactivated vaccine was first licensed for use in military populations during the 1940s. Recommendations for its use have expanded over the years to include groups at high risk for complications from influenza infection and their close contacts, including health care personnel, and recently also to include young children from 6 to 59 months of age and household contacts and . . . [Full Text of this Article]


Source Information

From the Influenza Division, Centers for Disease Control and Prevention, Atlanta.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.